What are the best routes to effectively model human colorectal cancer?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Oncology

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2013.02.006PMID 23465602PMCID PMC5528414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What are the best routes to effectively model human colorectal cancer?

  2013cited by this paper
• Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?

  2012cited by this paper
• Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models

  2012cited by this paper
• Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis

  2011cited by this paper
• Curcumin enhances dasatinib‐induced inhibition of growth and transformation of colon cancer cells

  2011cited by this paper
• Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma

  2010cited by this paper
• An integrated approach to uncover drivers of cancer.

  2010cited by this paper
• Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment

  2010cited by this paper
• The Mutyh Base Excision Repair Gene Influences the Inflammatory Response in a Mouse Model of Ulcerative Colitis

  2010cited by this paper
• Tgf-beta signaling alterations and colon cancer.

  2010cited by this paper
• A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.

  2010cited by this paper
• Transforming growth factor-β signaling in epithelial-mesenchymal transition and progression of cancer

  2009cited by this paper
• The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

  2009cited by this paper
• PTEN expression and mutation in colorectal carcinomas.

  2009cited by this paper
• Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.

  2009cited by this paper
• Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer.

  2009cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• Crypt stem cells as the cells-of-origin of intestinal cancer

  2009cited by this paper
• Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.

  2008cited by this paper
• Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation

  2008cited by this paper
• Deficiency of Mbd2 Attenuates Wnt Signaling

  2008cited by this paper
• Identification of Mom7, a Novel Modifier of ApcMin/+ on Mouse Chromosome 18

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

  2007cited by this paper
• Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.

  2007cited by this paper
• Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.

  2007cited by this paper
• Myc deletion rescues Apc deficiency in the small intestine

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• Molecular biology in colorectal cancer

  2006cited by this paper
• Transforming Growth Factor β Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation

  2006cited by this paper
• Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.

  2006cited by this paper
• Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

  2006cited by this paper
• Transforming Growth Factor B Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation

  2006cited by this paper
• Crypt dynamics and colorectal cancer: advances in mathematical modelling

  2006cited by this paper
• Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo

  2006cited by this paper
• Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice.

  2006cited by this paper
• Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

  2006cited by this paper
• Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine

  2005cited by this paper
• EphB receptor activity suppresses colorectal cancer progression (vol 435, pg 1126, 2005)

  2005cited by this paper
• Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.

  2005cited by this paper
• EphB receptor activity suppresses colorectal cancer progression

  2005cited by this paper
• Colorectal cancer: Mutations in a signalling pathway

  2005cited by this paper
• Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

  2005cited by this paper
• PPARδ status and Apc-mediated tumourigenesis in the mouse intestine

  2004cited by this paper
• PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.

  2004cited by this paper
• Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium

  2004cited by this paper
• Peroxisome proliferator–activated receptor-δ attenuates colon carcinogenesis

  2004cited by this paper
• Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

  2004cited by this paper
• Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

  2004cited by this paper
• Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac.

  2003cited by this paper
• Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer

  2002cited by this paper
• The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.

  2002cited by this paper
• Enhanced CpG Mutability and Tumorigenesis in MBD4-Deficient Mice

  2002cited by this paper
• Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.

  2002cited by this paper
• Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.

  2002cited by this paper
• Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice.

  2002cited by this paper
• ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

  2002cited by this paper
• The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.

  2001cited by this paper
• K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.

  2001cited by this paper
• Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen.

  2000cited by this paper
• The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.

  2000cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.

  2000cited by this paper
• Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

  2000cited by this paper
• Hereditary non-polyposis colorectal cancer: an updated review.

  2000cited by this paper
• An ultra-metastatic model of human colon cancer in nude mice

  1999cited by this paper
• Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.

  1999cited by this paper
• Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

  1999cited by this paper
• Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.

  1999cited by this paper
• Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.

  1998cited by this paper
• Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repair

  1998cited by this paper
• Piroxicam and Acarbose as Chemopreventive Agents for Spontaneous Intestinal Adenomas in APC Gene 1309 Knockout Mice

  1998cited by this paper
• Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.

  1997cited by this paper
• Molecular biology of colorectal cancer.

  1997cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.

  1996cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper
• Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.

  1995cited by this paper
• ApcMin: a mouse model for intestinal and mammary tumorigenesis.

  1995cited by this paper
• Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.

  1995cited by this paper
• A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

  1994cited by this paper
• The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

  1990cited by this paper
• Transforming growth factor beta.

  1988cited by this paper
• Prevalence of ras gene mutations in human colorectal cancers

  1987cited by this paper
• Cited Articles Citing Articles E-mail Alerts Estrogen Receptors a and B Are Inhibitory Modifiers of Apc- Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice

  year unknowncited by this paper

• Predicting colorectal cancer risk in FAP patients using patient-specific organoids

  2025cites this paper
• Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review

  2024cites this paper
• Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

  2024cites this paper
• MKRN1 promotes colorectal cancer metastasis by activating the TGF-β signalling pathway through SNIP1 protein degradation

  2023cites this paper
• Targeted delivery of aspirin and metformin to colorectal cancer using disulfide bridged nanoparticles of thiolated pectin and thiolated Eudragit RL100

  2023cites this paper
• Heterozygous APC germline mutations impart predisposition to colorectal cancer

  2021cites this paper
• Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis

  2021cites this paper
• Modeling colorectal cancers using multidimensional organoids.

  2021cites this paper
• Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials

  2020cites this paper
• Elevated adenomatous polyposis coli in goblet cells is associated with inflammation in mouse and human colon

  2020cites this paper
• Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer

  2020cites this paper
• Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma

  2020cites this paper
• Effect of Jackfruit-Derived Extract Consumption on Colitis-Associated Colon Tumorigenesis in Mice

  2020cites this paper
• The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models

  2020cites this paper
• Postoperative liver regeneration does not elicit recurrence of colorectal cancer liver metastases after major hepatectomy.

  2020cites this paper
• Resource Integrated In Vitro and In S ilico Modeling Delineates the Molecular Effects of a Synbiotic Regimen on Colorectal-Cancer-Derived Cells Graphical

  2019cites this paper
• Integrated In Vitro and In Silico Modeling Delineates the Molecular Effects of a Synbiotic Regimen on Colorectal-Cancer-Derived Cells.

  2019cites this paper
• The role of tetraspanin 6 in colorectal cancer

  2019cites this paper
• The interplay between intrinsic and extrinsic Wnt signaling in controlling intestinal transformation

  2019cites this paper
• Biodegradable Fluorescent Nanoparticles for Endoscopic Detection of Colorectal Carcinogenesis

  2019cites this paper
• Mouse models of gastrointestinal cancers in drug development and research

  2019cites this paper
• Human-cell-derived organoids as a new ex vivo model for drug assays in oncology.

  2018cites this paper
• Primary Colorectal Cells Culture as a Translational Research Model.

  2018cites this paper
• Tissue Organoids: Liver

  2018cites this paper
• Investigating the therapeutic potential of NUAK1 for the treatment of colorectal cancer

  2018influential citation
• Cross-talk between Hippo and Wnt signalling pathways in intestinal crypts: Insights from an agent-based model

  2018cites this paper
• The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models

  2018cites this paper
• A multi-site metastasis-on-a-chip microphysiological system for assessing metastatic preference of cancer cells.

  2018cites this paper
• Assessing Circulating Cell-free Tumour DNA as a Potential Biomarker for Early Detection and Chemoprevention of Colorectal Cancer

  2017cites this paper
• Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy

  2017cites this paper
• The Role of the Carcinoembryonic Antigen Receptor in Colorectal Cancer Progression

  2017cites this paper
• A genetically inducible porcine model of intestinal cancer

  2017cites this paper
• Human Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine

  2017cites this paper
• Targeting APC loss using synthetic lethality in colorectal cancer

  2017influential citation
• Bacteria-induced Wnt signalling as a mechanism for malignant development in the intestinal epithelium

  2017cites this paper
• Epithelial-stromal interaction in the pathogenesis of colorectal cancer

  2017cites this paper
• Rôles du couple TrkB/BDNF et de l’autophagie dans la survie de cellules de cancer colorectal

  2016cites this paper
• Dietary fat overcomes the protective activity of thrombospondin-1 signaling in the ApcMin/+ model of colon cancer

  2016cites this paper
• Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras

  2016cites this paper
• The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells

  2016cites this paper
• Effects of carrot consumption on intestinal cancer risk

  2016influential citation
• II . THE MOUSE GENOME IN COMPARISON TO MAN A

  2016cites this paper
• Fascin-1 as a biomarker and prospective therapeutic target in colorectal cancer

  2015cites this paper
• Targeting Heat Shock Proteins in Colorectal Cancer

  2015cites this paper
• Protocols for Analyzing the Role of Paneth Cells in Regenerating the Murine Intestine using Conditional Cre-lox Mouse Models

  2015cites this paper
• Heat Shock Protein-Based Therapies

  2015cites this paper
• Mouse models of intestinal cancer

  2015cites this paper
• Evaluating the effectiveness of cancer drug sensitization in vitro and in vivo.

  2015cites this paper
• Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro

  2015cites this paper
• The utility of Apc-mutant rats in modeling human colon cancer

  2014cites this paper
• Rodent Intestinal Epithelial Carcinogenesis

  2014cites this paper
• Differences in innate immune response between man and mouse.

  2014cites this paper
• Application of proteomics in the study of rodent models of cancer

  2014cites this paper
• What are the best routes to effectively model human colorectal cancer?

  2013cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper